Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 336
Immune Disorders Drugs 207
Biopharmaceuticals 176
Musculoskeletal Disorders Drugs 126
Genomics 116
Cardiovascular Drugs 104
Biotechnology 84
Pharmaceuticals 79
Drug Discovery 77
Endocrine and Metabolic Disorders Drugs 76
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 65
Leukemia Drugs 63
Hematological Drugs 60
Clinical Trials 54
Oncology 52
Dermatological Drugs 51
Central Nervous System Drugs 49
Women's Health 45
Liver and Kidney Disorders Drugs 45
Needles and Syringes 42
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Enzymes 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Gastrointestinal Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Dermatology 19
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Optical 17
Therapeutic Area 16
Respiratory Drugs 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Gastroenterology 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,087 Results (Page 89 of 105)
- Relevance
  Sort by

HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market 2024-2028

 Report
October 2023
164 Pages
Global

From

€2190EUR$2,500USD£1,900GBP

Anaplastic Astrocytoma Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Targeted Therapy Market Report 2025

 Report
March 2025
175 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Macrophage Colony Stimulating Factor Receptor Antagonists - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€1752EUR$2,000USD£1,520GBP

Soft Tissue Sarcoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
280 Pages
Global

From

€2627EUR$3,000USD£2,280GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Ewing Sarcoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
115 Pages
Global

From

€1752EUR$2,000USD£1,520GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

 Report
April 2021
179 Pages
Global

From

€2190EUR$2,500USD£1,900GBP

€4379EUR$5,000USD£3,801GBP

South & Central America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
220 Pages

From

€3022EUR$3,450USD£2,623GBP

Middle East & Africa Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
230 Pages
Africa, Middle East

From

€3022EUR$3,450USD£2,623GBP

Europe Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
253 Pages
Europe

From

€3022EUR$3,450USD£2,623GBP

North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

 Report
July 2023
224 Pages
North America

From

€3022EUR$3,450USD£2,623GBP

The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition

 Report
June 2025
127 Pages
Global

From

€2584EUR$2,950USD£2,242GBP

CAR-T - Pipeline Insight, 2025

 Clinical Trials
April 2025
450 Pages
Global

From

€4379EUR$5,000USD£3,801GBP

Minimal Residual Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1752EUR$2,000USD£1,520GBP

Adenoid Cystic Carcinoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€3941EUR$4,500USD£3,421GBP

Metastatic Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€3941EUR$4,500USD£3,421GBP

Bone Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
184 Pages
Global

From

€3941EUR$4,500USD£3,421GBP

Revenue Cycle Management Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4334EUR$4,949USD£3,762GBP

11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1095EUR$1,250USD£950GBP

2,087 Results (Page 89 of 105)
- 1
- 87
- 88
- 89
- 90
- 91

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.